Veradermics, Inc — Form SCHEDULE 13D/A
Filed August 14, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 22/100
What the filing says
On August 14, 2026, multiple entities controlled by Simeon George, M.D. through SR One Capital Management, LLC (including SR One Capital Fund II Aggregator LP, SR One Capital Partners II LP, AMZL LP, SR One Capital SMA Partners LP, and numerous co-investment vehicles) executed a joint filing agreement under Rule 13d-1(k)(1) to file a single Schedule 13D statement regarding their aggregate ownership of Veradermics, Inc. The filing establishes a power of attorney authorizing Sasha Keough, Karen Narolewski-Engel, James Macadam, and Alexander M. Bowling to execute SEC filings on behalf of all named filers. No specific share count, percentage ownership, or dollar amounts are disclosed in this exhibit.
Why this rating
Procedural filing coordinating disclosure obligations; no ownership data, transaction, or material change disclosed. Administrative consolidation of filing responsibility.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.